Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.
<h4>Objectives</h4>Cryptococcal meningitis (CM)-related mortality may be prevented by screening patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) initiation and pre-emptively treating those testing positive. Prior to programmatic implementation in...
Saved in:
| Main Authors: | Joseph N Jarvis, Thomas S Harrison, Stephen D Lawn, Graeme Meintjes, Robin Wood, Susan Cleary |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0069288 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa.
by: Mathew A Beale, et al.
Published: (2015-01-01) -
Household economic impact of HIV‐associated cryptococcal meningitis in five countries in Southern and Eastern Africa
by: David S. Lawrence, et al.
Published: (2025-06-01) -
Cryptococcal Meningitis in an HIV-Negative Puerperal Woman
by: Tomás Robalo Nunes, et al.
Published: (2021-01-01) -
Alcohol production in cryptococcal meningitis
by: Viroj Wiwanitkit
Published: (2012-03-01) -
Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis.
by: Anil A Panackal, et al.
Published: (2015-05-01)